Medici Brands, a New York-based food and beverage company, has raised $250 million in Series B financing. The round was co-led by existing investors Greenoaks and Valor Equity Partners, with participation from CEO Peter Rahal, ICONIQ and Imaginary Ventures.
Medici Brands is the parent company of David Protein and HallPass, while its wider portfolio also includes food ingredient company Epogee. David launched direct-to-consumer in September 2024 and has since expanded from protein bars into frozen desserts and ready-to-drink shakes. Its products are sold across more than 35,000 retail locations, including Walmart, Target and Costco.
HallPass, Medici’s confectionery brand, launched nationwide at Walmart in August 2026. The company also plans to introduce another consumer brand, Rowdy, later in 2026.
Medici said the new capital will support the expansion of HallPass’ retail presence and product portfolio, extend David into additional formats and categories, advance product innovation, and build infrastructure for launching and scaling new brands. Greenoaks and Valor Equity Partners previously invested in David’s $75 million Series A financing in 2025.
